Antagen Pharmaceuticals Signs Agreement with i-DNA Biotechnology Sdn Bhd

Antagen Pharmaceuticals Signs Agreement with i-DNA Biotechnology Pte. Ltd. for Distribution of its Products in Singapore. Antagen Pharmaceuticals announced it that has selected and signed an agreement with i-DNA Biotechnology Pte. Ltd. for distribution of Antagen Pharmaceuticals products and services in Southeast Asia.

Antagen is developing therapeutic antibodies for patients with cancer, autoimmune and infectious diseases, we also strive to serve the scientific community, and strengthen our research alliance through better products and services.

Additionally, Antagen has developed rapid tests for quick measurement of lentivirus titres, which is a crucial step for scientists using lentivirus as a gene delivery tool for basic research or for CAR-T therapy. Our second-generation LentiTitre cassette has 4 lanes that allow sample to be compared side-by-side with lentivirus standards with known titres. Results can be obtained in as little as 5 min, compared to days by the conventional infection method. All the above rapid tests are being sold to thousands of labs throughout our worldwide distributor network.